TAMSULOSIN HYDROCHL

The U.S. Defense Logistics Agency awarded a fixed-price delivery order to DMS PHARMACEUTICAL GROUP INC under solicitation SPE2DP26F7446, with a total contract value of $351.89, awarded on July 14, 2026. The order, issued under the base contract SPE2DX25D9900, requires delivery of one unit of TAMSULOSIN HYDROCHLORIDE identified by NSN 6505017104572 and NDC 62135-0775-90, with a strict quantity variance allowance of plus or minus 0.00%. Delivery is due by July 29, 2026, at Fort Carson, Colorado, under FOB destination terms, meaning the contractor bears all costs and risks until the item reaches the destination. Inspection and acceptance occur at the delivery point, and shipping must be conducted via traceable means, excluding parcel post. The packaging and marking must include the full shipping address, NSN, TCN W91M2360960211, and manufacturer and supplier CAGE codes 8APGO and 0PUV4, though no specific MIL-STD packaging or labeling standards are referenced. Payment responsibilities lie with the contractor, and the invoice remittance address is listed as W91M23, 0010 SF BN CO A GSB, AWCF SSF, BLDG 7465 BAD TOELZ RD, FORT CARSON, CO 80913-4093, with procurement funded under PR number 7017495981, DIC code A0A, and fund code Z9. The contractor’s CAGE code is 1UNB0, but no socioeconomic status, small business certification, or affirmative representations are documented. No clauses from FAR or DFARS are explicitly stated in the contract documents, and there are no listed attachments, evaluation factors, special requirements, or point of contact information provided. The award appears to be a minimal-scope, low-value procurement executed under existing contracting mechanisms with limited contractual detail beyond logistical and product specifications.